Chamberlain JR - Search Results

1

Impact of clinical training on violence risk assessment.

McNiel DE, Chamberlain JR, Weaver CM, Hall SE, Fordwood SR, Binder RL. McNiel DE, et al. Among authors: chamberlain jr. Am J Psychiatry. 2008 Feb;165(2):195-200. doi: 10.1176/appi.ajp.2007.06081396. Am J Psychiatry. 2008. PMID: 18245189 No abstract available.

2

Effects of training on suicide risk assessment.

McNiel DE, Fordwood SR, Weaver CM, Chamberlain JR, Hall SE, Binder RL. McNiel DE, et al. Among authors: chamberlain jr. Psychiatr Serv. 2008 Dec;59(12):1462-5. doi: 10.1176/ps.2008.59.12.1462. Psychiatr Serv. 2008. PMID: 19033175

3

Government Management of Accompanied Minors Held in the Custody of Immigration Authorities.

Armontrout JA, Chamberlain JR. Armontrout JA, et al. Among authors: chamberlain jr. J Am Acad Psychiatry Law. 2017 Jun;45(2):269-271. J Am Acad Psychiatry Law. 2017. PMID: 28619877 No abstract available.

4

Clarification to Prison Litigation Reform Act "Three Strikes" Rule.

Datta V, Michaels TM, Chamberlain JR. Datta V, et al. Among authors: chamberlain jr. J Am Acad Psychiatry Law. 2017 Jun;45(2):271-273. J Am Acad Psychiatry Law. 2017. PMID: 28619878 No abstract available.

5

Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity.

Course MM, Gudsnuk K, Desai N, Chamberlain JR, Valdmanis PN. Course MM, et al. Among authors: chamberlain jr. Mol Ther Nucleic Acids. 2020 Mar 6;19:572-580. doi: 10.1016/j.omtn.2019.12.007. Epub 2019 Dec 18. Mol Ther Nucleic Acids. 2020. PMID: 31927330 Free PMC article.

6

Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.

Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS. Bengtsson NE, et al. Among authors: chamberlain jr. Nat Commun. 2017 Jun 23;8:16007. doi: 10.1038/ncomms16007. Nat Commun. 2017. PMID: 28643790 Free PMC article.

7

Progress toward Gene Therapy for Duchenne Muscular Dystrophy.

Chamberlain JR, Chamberlain JS. Chamberlain JR, et al. Mol Ther. 2017 May 3;25(5):1125-1131. doi: 10.1016/j.ymthe.2017.02.019. Epub 2017 Apr 15. Mol Ther. 2017. PMID: 28416280 Free PMC article. Review.

8

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.

Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS. Bengtsson NE, et al. Among authors: chamberlain jr. Nat Commun. 2017 Feb 14;8:14454. doi: 10.1038/ncomms14454. Nat Commun. 2017. PMID: 28195574 Free PMC article.

9

Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.

Bisset DR, Stepniak-Konieczna EA, Zavaljevski M, Wei J, Carter GT, Weiss MD, Chamberlain JR. Bisset DR, et al. Among authors: chamberlain jr. Hum Mol Genet. 2015 Sep 1;24(17):4971-83. doi: 10.1093/hmg/ddv219. Epub 2015 Jun 16. Hum Mol Genet. 2015. PMID: 26082468 Free PMC article.

10

Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells.

Arnett AL, Konieczny P, Ramos JN, Hall J, Odom G, Yablonka-Reuveni Z, Chamberlain JR, Chamberlain JS. Arnett AL, et al. Among authors: chamberlain jr. Mol Ther Methods Clin Dev. 2014;1:14038-. doi: 10.1038/mtm.2014.38. Mol Ther Methods Clin Dev. 2014. PMID: 25580445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results